Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy
The regenerative capacity of muscle stem cells is impaired in Duchenne muscular dystrophy (DMD). Here, the authors show that the endocannabinoid receptor CB1 is activated by PAX7 in muscle stem cells, and that pharmacological inhibition of CB1 promotes stem cell activation and ameliorates symptoms i...
Guardado en:
Autores principales: | Fabio A. Iannotti, Ester Pagano, Ombretta Guardiola, Simone Adinolfi, Valentina Saccone, Silvia Consalvi, Fabiana Piscitelli, Elisabetta Gazzerro, Giuseppe Busetto, Diego Carrella, Raffaele Capasso, Pier Lorenzo Puri, Gabriella Minchiotti, Vincenzo Di Marzo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/18374656998d4f538355e4174ad2ce20 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Computer task performance by subjects with Duchenne muscular dystrophy
por: Malheiros SRP, et al.
Publicado: (2015) -
Current and emerging treatment strategies for Duchenne muscular dystrophy
por: Mah JK
Publicado: (2016) -
Prediction of essential binding domains for the endocannabinoid N-arachidonoylethanolamine (AEA) in the brain cannabinoid CB1 receptor.
por: Joong-Youn Shim
Publicado: (2021) -
Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy
por: Marshall W. Hogarth, et al.
Publicado: (2017) -
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy.
por: Elena Stacy Mazzone, et al.
Publicado: (2013)